Event agenda

Welcome and Coffee Reception

Welcome address - Eric Vivier, President of the Paris-Saclay Cancer Cluster

Eric Vivier, DVM, PhD, is Professor of Immunology, AMU-APHM - Professor, Ecole Polytechnique - Chief Science Officer, Innate Pharma - ´Natural Killer Cells’ Chair, Fondation Gustave Roussy - and President, Paris Saclay Cancer Cluster.

Bioinformatics strategies to target cancer genomes for precision oncology - Fatima Al-Shahrour

Fatima Al-Shahrour, PhD, is Head of the Bioinformatics Unit at Spanish National Cancer Research Center (CNIO). Fatima Al-Shahrour is a member of the PSCC's Strategic Advisory Board.

T cell recognition of human cancer - Ton Schumacher

Ton Schumacher is a member of the PSCC's Strategic Advisory Board Senior member of The Netherlands Cancer Institute, Oncode Institute, and Professor of Immunotechnology at Leiden University.

Targeting the DNA damage response: from bench to clinic - Thomas Helleday

Thomas Helleday, PhD, is Professor of Translational Medicine and Chemical Biology at the Karolinska Institute, Sweden, where he holds the Torsten and Ragnar Söderberg Chair. Thomas Helleday is a member of the PSCC's Strategic Advisory Board.

Break - networking

IA and complex patient data for personnalized medicine - Vassili Soumelis

Vassili Soumelis, MD, PhD, is Chief Medical Officer at Owkin. He specializes in hemato-oncology, dermatology, allergy, auto-inflammatory disorders, immunotherapy, and systems biology, with a focus on immunology, dendritic cells, T cells, and cytokines.

Harnessing Natural Killer cells in cancer therapies- Eric Vivier

Eric Vivier, DVM, PhD, is Professor of Immunology, AMU-APHM - Professor, Ecole Polytechnique - Chief Science Officer, Innate Pharma - ´Natural Killer Cells’ Chair, Fondation Gustave Roussy - and President, Paris Saclay Cancer Cluster.

Lunch break - networking

PSCC: 2024 in Achievements, 2025 in Focus

Benjamin Garel, CEO of the Paris-Saclay Cancer Cluster

Accelerating innovation through cross-collaborations

Focus on expertise, technology platforms & Campus Grand Parc site offer

Shaping the future: Innovation in oncology vs. other therapeutic areas - France Biotech

Spotlight on Innovation: Portfolio Highlights and 4 Startup Pitches by PSCC - part 1

Portfolio overview Pitches of Brenus pharma & Deeplife (10'+5' QA each)

Break - networking

Spotlight on Innovation: 4 Startup Pitches by PSCC - part 2

Pitches of Stimunity & Robeauté (10'+5' QA each)

Inspiring talk

Surprise guest

Conclusion

Cocktail at Campus Grand Parc (Perelis building)

Pitch award ceremony and networking